...
首页> 外文期刊>The Journal of Pharmacology and Experimental Therapeutics: Official Publication of the American Society for Pharmacology and Experimental Therapeutics >Endothelial nitric oxide synthase-independent release of nitric oxide in the aorta of the spontaneously hypertensive rat
【24h】

Endothelial nitric oxide synthase-independent release of nitric oxide in the aorta of the spontaneously hypertensive rat

机译:自发性高血压大鼠主动脉内皮一氧化氮合酶的释放

获取原文
获取原文并翻译 | 示例

摘要

In the aorta of male spontaneously hypertensive rats (SHR), but not in that of normotensive Wistar-Kyoto rats (WKY), contractions to phenylephrine obtained in the presence of L-NAME [inhibitor of nitric oxide synthase (NOS)] and indomethacin (inhibitor of cyclooxygenase) are inhibited by an unknown endothelium-derived factor. The present study aimed to identify the mechanism underlying this endothelium-dependent inhibition in the SHR aorta. Aortic rings of male SHR and WKY, with and without endothelium, were suspended in organ chambers in the presence of indomethacin and L-NAME for the measurement of isometric tension. Contractions to phenylephrine were smaller in SHR aortae with endothelium than in those without, but were similar in the two types of preparations of WKY aortae. The endothelium-dependent, NOS-independent inhibition of phenylephrine-induced contraction was abolished by oxyhemoglobin [extracellular NO scavenger], carboxy-PTIO (NO scavenger) and ODQ (inhibitor of soluble guanylyl cyclase). It was unmasked not only by indomethacin but also by apocynin (antioxidant), but inhibited by diphenyleneiodonium (inhibitor of flavoproteins including cytochrome P450 reductase). The cytochrome P450 reductase protein expression was similar in SHR and WKY aortae. However, the level of nitrate and nitrite, substrates of cytochrome P450 reductase, were higher in SHR than WKY plasma and aortae. Therefore, in SHR but not WKY aortae, eNOS-independent NO is formed by cytochrome P450 reductase.
机译:在雄性自发性高血压大鼠(SHR)的主动脉中,而非在正常血压的Wistar-Kyoto大鼠(WKY)的主动脉中,在L-NAME [一氧化氮合酶抑制剂(NOS)抑制剂]和消炎痛(被未知的内皮源因子抑制。本研究旨在确定SHR主动脉中这种内皮依赖性抑制的基础机制。在吲哚美辛和L-NAME的存在下,将雄性SHR和WKY(带有和不带有内皮)的主动脉环悬挂在器官室内,以测量等轴测张力。有内皮的SHR主动脉的去氧肾上腺素收缩比没有内皮的收缩小,但在两种WKY主动脉制剂中相似。氧合血红蛋白[细胞外NO清除剂],羧基-PTIO(NO清除剂)和ODQ(可溶性鸟嘌呤环化酶抑制剂)取消了对苯肾上腺素诱导的收缩的内皮依赖性,非NOS依赖性抑制。它不仅被消炎痛所掩盖,还被载脂蛋白(抗氧化剂)所掩盖,但被二苯撑碘鎓(包括细胞色素P450还原酶的黄素抑制剂)所抑制。 SHR和WKY主动脉中的细胞色素P450还原酶蛋白表达相似。然而,SHR中硝酸盐和亚硝酸盐(细胞色素P450还原酶的底物)水平高于WKY血浆和主动脉。因此,在SHR中而不是WKY主动脉中,细胞色素P450还原酶形成eNOS依赖性NO。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号